Joan Kyula

1.6k total citations
33 papers, 1.0k citations indexed

About

Joan Kyula is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Joan Kyula has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 20 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Joan Kyula's work include Virus-based gene therapy research (21 papers), CAR-T cell therapy research (12 papers) and Cancer Research and Treatments (10 papers). Joan Kyula is often cited by papers focused on Virus-based gene therapy research (21 papers), CAR-T cell therapy research (12 papers) and Cancer Research and Treatments (10 papers). Joan Kyula collaborates with scholars based in United Kingdom, United States and Canada. Joan Kyula's co-authors include Kevin J. Harrington, Victoria Roulstone, David Mansfield, Martin McLaughlin, Daniel B. Longley, Patrick G. Johnston, Sandra Van Schaeybroeck, Alan Melcher, Henry Smith and Aadil Khan and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Joan Kyula

31 papers receiving 995 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joan Kyula United Kingdom	21	576	460	443	161	142	33	1.0k
Kang Hu China	19	536 0.9×	618 1.3×	532 1.2×	216 1.3×	157 1.1×	27	1.3k
Conrado Soria United States	8	476 0.8×	558 1.2×	519 1.2×	100 0.6×	126 0.9×	8	913
Norman Woller Germany	20	886 1.5×	467 1.0×	472 1.1×	595 3.7×	120 0.8×	36	1.5k
Engin Gürlevik Germany	17	564 1.0×	460 1.0×	313 0.7×	417 2.6×	85 0.6×	21	1.1k
Gerd Bauerschmitz Germany	23	930 1.6×	1.0k 2.2×	1.3k 2.9×	114 0.7×	287 2.0×	55	1.6k
Edward A. Hirschowitz United States	19	545 0.9×	835 1.8×	489 1.1×	446 2.8×	207 1.5×	30	1.5k
Gail DeRaffele United States	12	785 1.4×	336 0.7×	392 0.9×	624 3.9×	68 0.5×	19	1.1k
Lynette P. Steele United Kingdom	15	506 0.9×	362 0.8×	613 1.4×	337 2.1×	166 1.2×	19	1.0k
Patricia Roxburgh United Kingdom	14	491 0.9×	296 0.6×	191 0.4×	123 0.8×	46 0.3×	50	754
Patrice Yeh France	21	371 0.6×	1.1k 2.4×	750 1.7×	109 0.7×	176 1.2×	25	1.6k

Countries citing papers authored by Joan Kyula

Since Specialization

Citations

This map shows the geographic impact of Joan Kyula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Kyula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Kyula more than expected).

Fields of papers citing papers by Joan Kyula

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Kyula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Kyula. The network helps show where Joan Kyula may publish in the future.

Co-authorship network of co-authors of Joan Kyula

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Kyula. A scholar is included among the top collaborators of Joan Kyula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Kyula. Joan Kyula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hak, Charleen Chan Wah, Emmanuel C. Patin, Annalisa Nicastri, et al.. (2025). Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer. Cancer Research Communications. 5(11). 2079–2091.

Foo, Shane, Pablo Nenclares, Martin McLaughlin, et al.. (2024). Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling. Journal for ImmunoTherapy of Cancer. 12(7). e009443–e009443. 5 indexed citations

Paget, James, Janice Ward, David Mansfield, et al.. (2024). CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues. Molecular Cancer Therapeutics. 24(3). 431–443.

McLaughlin, Martin, Malin Pedersen, Victoria Roulstone, et al.. (2020). The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism. Molecular Therapy — Oncolytics. 16. 238–249. 24 indexed citations

Smith, Henry, David Mansfield, Victoria Roulstone, et al.. (2019). PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma. Clinical Cancer Research. 25(11). 3443–3454. 23 indexed citations

Thomas, Suzanne, Victoria Roulstone, Joan Kyula, et al.. (2019). Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1. Journal for ImmunoTherapy of Cancer. 7(1). 214–214. 119 indexed citations

Khan, Aadil, James Paget, Martin McLaughlin, et al.. (2018). Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues. Science Translational Medicine. 10(425). 17 indexed citations

Comins, Charles, Guy R. Simpson, William Rogers, et al.. (2018). Synergistic antitumour effects of rapamycin and oncolytic reovirus. Cancer Gene Therapy. 25(5-6). 148–160. 9 indexed citations

Patel, Radhika, Holly E. Barker, Joan Kyula, et al.. (2017). An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. Radiotherapy and Oncology. 122(3). 470–475. 20 indexed citations

10.

Mansfield, David, Joan Kyula, Gabriela Krämer-Marek, et al.. (2016). Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer. Gene Therapy. 23(4). 357–368. 46 indexed citations

11.

Roulstone, Victoria, Malin Pedersen, Joan Kyula, et al.. (2015). BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress. Molecular Therapy. 23(5). 931–942. 38 indexed citations

12.

Seth, Rohit, Aadil Khan, Michelle Wilkinson, et al.. (2015). Adenovirally Delivered Enzyme Prodrug Therapy with Herpes Simplex Virus–Thymidine Kinase in Composite Tissue Free Flaps Shows Therapeutic Efficacy in Rat Models of Glioma. Plastic & Reconstructive Surgery. 135(2). 475–487. 5 indexed citations

13.

Schick, Ulrike, Joan Kyula, Holly E. Barker, et al.. (2015). Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence. Radiotherapy and Oncology. 117(2). 364–375. 26 indexed citations

14.

Kyula, Joan, Aadil Khan, David Mansfield, et al.. (2013). Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling. Oncogene. 33(13). 1700–1712. 33 indexed citations

15.

Twigger, Katie, Victoria Roulstone, Joan Kyula, et al.. (2012). Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. BMC Cancer. 12(1). 368–368. 46 indexed citations

16.

Mansfield, David, Joan Kyula, S. Zaidi, et al.. (2012). Oncolytic Vaccinia virus and radiotherapy in head and neck cancer. Oral Oncology. 49(2). 108–118. 31 indexed citations

17.

Borst, Gerben R., Martin McLaughlin, Joan Kyula, et al.. (2012). Targeted Radiosensitization by the Chk1 Inhibitor SAR-020106. International Journal of Radiation Oncology*Biology*Physics. 85(4). 1110–1118. 44 indexed citations

18.

Kyula, Joan, Victoria Roulstone, Eleni Karapanagiotou, Alan Melcher, & Kevin J. Harrington. (2012). Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer. Expert Opinion on Biological Therapy. 12(12). 1669–1678. 20 indexed citations

19.

Schaeybroeck, Sandra Van, Joan Kyula, Takehiko Sasazuki, et al.. (2010). Oncogenic Kras Promotes Chemotherapy-Induced Growth Factor Shedding via ADAM17. Cancer Research. 71(3). 1071–1080. 39 indexed citations

20.

Kyula, Joan, et al.. (2010). Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer. Clinical Cancer Research. 16(13). 3378–3389. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact